ERK5 is a target for gene amplification at 17p11 and promotes cell growth in hepatocellular carcinoma by regulating mitotic entry

Genes Chromosomes and Cancer

Volumn 48, Issue 2, 2009, Pages 109-120

  Zen, Keika ^a   Yasui, Kohichiroh ^a   Nakajima, Tomoaki ^a   Zen, Yoh ^b   Zen, Kan ^c   Gen, Yasuyuki ^a   Mitsuyoshi, Hironori ^a   Minami, Masahito ^a   Mitsufuji, Shoji ^a   Tanaka, Shinji ^d   Itoh, Yoshito ^a   Nakanuma, Yasuni ^b   Taniwaki, Masafumi ^a   Arii, Shigeki ^d   Okanoue, Takeshi ^a   Yoshikawa, Toshikazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c Omihachiman Community Medical Center   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MITOGEN ACTIVATED PROTEIN KINASE 7; OLIGONUCLEOTIDE; SMALL INTERFERING RNA;

AMPLICON; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL GROWTH; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MICROARRAY ANALYSIS; MITOSIS; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL LINE, TUMOR; CHI-SQUARE DISTRIBUTION; CHROMOSOMES, HUMAN, PAIR 17; DOWN-REGULATION; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE ORDER; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MITOGEN-ACTIVATED PROTEIN KINASE 7; MITOSIS; MITOTIC INDEX; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 59949097637     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20624     Document Type: Article

References (56)

1. Aden DP, Fogel A, Plotkin S, Damjanov I, Knowles BB. 1979. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 282:615-616.
2. Alexander JJ, Bey EM, Geddes EW, Lecatsas G. 1976. Establishment of a continuously growing cell line from primary carcinoma of the liver. S Afr Med J 50:2124-2128.
3. Bignell GR, Huang J, Greshock J, Watt S, Butler A, West S, Grigorova M, Jones KW, Wei W, Stratton MR, Futreal PA, Weber B, Shapero MH, Wooster R. 2004. High-resolution analysis of DNA copy number using oligonucleotide microarrays. Genome Res 14:287-295.
4. Buschbeck M, Hofbauer S, Di Croce L, Keri G, Ullrich A. 2005. Abl-kinase-sensitive levels of ERK5 and its intrinsic basal activity contribute to leukaemia cell survival. EMBO Rep 6:63-69.
5. Carvajal-Vergara X, Tabera S, Montero JC, Esparís-Ogando A, López-Pérez R, Mateo G, Gutiérrez N, Parmo-Cabañas M, Teixidó J, San Miguel JF, Pandiella A. 2005. Multifunctional role of Erk5 in multiple myeloma. Blood 105:4492-4499.
6. Chiariello M, Marinissen MJ, Gutkind JS. 2000. Multiple mitogen-activated protein kinase signaling pathways connect the cot oncoprotein to the c-jun promoter and to cellular transformation. Mol Cell Biol 20:1747-1758.
7. Collins C, Rommens JM, Kowbel D, Godfrey T, Tanner M, Hwang SI, Polikoff D, Nonet G, Cochran J, Myambo K, Jay KE, Froula J, Cloutier T, Kuo WL, Yaswen P, Dairkee S, Giovanola J, Hutchinson GB, Isola J, Kallioniemi OP, Palazzolo M, Martin C, Ericsson C, Pinkel D, Albertson D, Li WB, Gray JW. 1998. Positional cloning of ZNF217 and NABC1: Genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc Natl Acad Sci USA 95:8703-8708.
8. Cude K, Wang Y, Choi HJ, Hsuan SL, Zhang H, Wang CY, Xia Z. 2007. Regulation of the G2-M cell cycle progression by the ERK5-NFkappaB signaling pathway. J Cell Biol 177:253-264.
9. Fiore PP, Pierce JH, Kraus MH, Segatto O, King CR, Aaron-son SA. 1987. erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science 237:178-182.
10. X, Matsuzaki H, Webster TA, Hubbell E, Liu G, Dong S, Bar-tell D, Huang J, Chiles R, Yang G, Shen MM, Kulp D, Kennedy GC, Mei R, Jones KW, Cawley S. 2005. Dynamic model based algorithms for screening and genotyping over 100 K SNPs on oligonucleotide microarrays. Bioinformatics 21:1958-1963.
11. Dor I, Namba M, Sato J. 1975. Establishment and some biological characteristics of human hepatoma cell lines. Gann 66:385-392.
12. El-Serag HB. 2002. Hepatocellular carcinoma: An epidemiologic view. J Clin Gastroenterol 35:S72-S78.
13. English JM, Pearson G, Hockenberry T, Shivakumar L, White MA, Cobb MH. 1999. Contribution of the ERK5/MEK5 pathway to Ras/Raf signaling and growth control. J Biol Chem 274:31588-1592.
14. Esparis-Ogando A, Diaz-Rodriguez E, Montero JC, Yuste L, Crespo P, Pandiella A. 2002. Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2. Mol Cell Biol 22:270-285.
15. Forus A, Weghuis DO, Smeets D, Fodstad O, Myklebost O, Geurts van Kessel A. 1995. Comparative genomic hybridization analysis of human sarcomas. II. Identification of novel amplicons at 6p and 17p in osteosarcomas. Genes Chromosomes Cancer 14:15-21.
16. Fujise K, Nagamori S, Hasumura S, Homma S, Sujino H, Matsuura T, Shimizu K, Niiya M, Kameda H, Fujita K. 1990. Integration of hepatitis B virus DNA into cells of six established human hepatocellular carcinoma cell lines. Hepatogastroenterology 37:457-460.
17. Garaude J, Cherni S, Kaminski S, Delepine E, Chable-Bessia C, Benkirane M, Borges J, Pandiella A, Iñiguez MA, Fresno M, Hipskind RA, Villalba M. 2006. ERK5 activates NF-kappaB in leukemic T cells and is essential for their growth in vivo. J Immunol 177:7607-7617.
18. Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, Li C, Golub TR, Rimm DL, Meyerson ML, Fisher DE, Sellers WR. 2005. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436:117-122.
19. Gírio A, Montero JC, Pandiella A, Chatterjee S. 2007. Erk5 is activated and acts as a survival factor in mitosis. Cell Signal 19:1964-1972.
20. Hayashi M, Lee JD. 2004. Role of the BMK1/ERK5 signaling pathway: Lessons from knockout mice. J Mol Med 82:800-808.
21. Hirohashi S, Shimosato Y, Kameya T, Koide T, Mukojima T, Taguchi Y, Kageyama K. 1979. Production of -fetoprotein and normal serum proteins by xenotransplanted human hepatomas in relation to their growth and morphology. Cancer Res 39: 1819-1828.
22. Huh N, Utakoji T. 1981. Production of HBs-antigen by two new human hepatoma cell lines and its enhancement by dexamethasone. Gann 72:178-179.
23. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D. 1992. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821.
24. Kato Y, Kravchenko VV, Tapping RI, Han J, Ulevitch RJ, Lee JD. 1997. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J 16:7054-7066.
25. Kato Y, Tapping RI, Huang S, Watson MH, Ulevitch RJ, Lee JD. 1998. Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor. Nature 395:713-716.
26. Kennedy GC, Matsuzaki H, Dong S, Liu WM, Huang J, Liu G, Su X, Cao M, Chen W, Zhang J, Liu W, Yang G, Di X, Ryder T, He Z, Surti U, Phillips MS, Boyce-Jacino MT, Fodor SP, Jones KW. 2003. Large-scale genotyping of complex DNA. Nat Biotechnol 21:1233-1237.
27. Knowles BB, Howe CC, Aden DP. 1980. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 209:97-499.
28. Linnerth NM, Baldwin M, Campbell C, Brown M, McGowan H, Moorehead RA. 2005. IGF-II induces CREB phosphorylation and cell survival in human lung cancer cells. Oncogene 24:7310-7319.
29. Little CD, Nau MM, Carney DN, Gazdar AF, Minna JD. 1983. Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature 306:194-196.
30. Matsuzaki H, Dong S, Loi H, Di X, Liu G, Hubbell E, Law J, Berntsen T, Chadha M, Hui H, Yang G, Kennedy GC, Webster TA, Cawley S, Walsh PS, Jones KW, Fodor SP, Mei R. 2004a. Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays. Nat Methods 1:109-111.
31. Matsuzaki H, Loi H, Dong S, Tsai YY, Fang J, Law J, Di X, Liu WM, Yang G, Liu G, Huang J, Kennedy GC, Ryder TB, Marcus GA, Walsh PS, Shriver MD, Puck JM, Jones KW, Mei R. 2004b. Parallel genotyping of over 10,000 SNPs using a one-primer assay on a high-density oligonucleotide array. Genome Res 14:414-425.
32. McCracken SR, Ramsay A, Heer R, Mathers ME, Jenkins BL, Edwards J, Robson CN, Marquez R, Cohen P, Leung HY. 2008. Aberrant expression of extracellular signal-regulated kinase 5 in human prostate cancer. Oncogene 27:2978-2988.
33. Mehta PB, Jenkins BL, McCarthy L, Thilak L, Robson CN, Neal DE, Leung HY. 2003. MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion. Oncogene 22:1381-1389.
34. Mei R, Galipeau PC, Prass C, Berno A, Ghandour G, Patil N, Wolff RK, Chee MS, Reid BJ, Lockhart DJ. 2000. Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays. Genome Res 10:1126-1137.
35. Minamiya Y, Matsuzaki I, Sageshima M, Saito H, Taguchi K, Nakagawa T, Ogawa J. 2004. Expression of tissue factor mRNA and invasion of blood vessels by tumor cells in non-small cell lung cancer. Surg Today 34:1-5.
36. Mulloy R, Salinas S, Philips A, Hipskind RA. 2003. Activation of cyclin D1 expression by the ERK5 cascade. Oncogene 22:5387-5398.
37. Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J. 1982. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res 42:3858-3863.
38. Nannya Y, Sanada M, Nakazaki K, Hosoya N, Wang L, Hangaishi A, Kurokawa M, Chiba S, Bailey DK, Kennedy GC, Ogawa S. 2005. A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism geno-typing arrays. Cancer Res 65:6071-6079.
39. Nishimoto S, Nishida E. 2006. MAPK signalling: ERK5 versus ERK1/2. EMBO Rep 7:782-786.
40. Okamoto H, Yasui K, Zhao C, Arii S, Inazawa J. 2003. PTK2 and EIF3S3 genes may be amplification targets at 8q23-q24 and are associated with large hepatocellular carcinomas. Hepatology 38:1242-1249.
41. Park JG, Lee JH, Kang MS, Park KJ, Jeon YM, Lee HJ, Kwon HS, Park HS, Yeo KS, Lee KU, Kim ST, Chung JK, Hwang YJ,
42. Lee HS, Kim CY, Lee YI, Chen TR, Hay RJ, Song SY, Kim WH, Kim CW, Kim YI. 1995. Characterization of cell lines established from human hepatocellular carcinoma. Int J Cancer 62:276-282.
43. Rosenthal JA, Chen H, Slepnev VI, Pellegrini L, Salcini AE, Di Fiore PP, De Camilli P. 1999. The epsins define a family of proteins that interact with components of the clathrin coat and contain a new protein module. J Biol Chem 274:33959-33965.
44. Sun W, Wei X, Kesavan K, Garrington TP, Fan R, Mei J, Anderson SM, Gelfand EW, Johnson GL. 2003. MEK kinase 2 and the adaptor protein Lad regulate extracellular signal-regulated kinase 5 activation by epidermal growth factor via Src. Mol Cell Biol 23:2298-2308.
45. Tarkkanen M, Karhu R, Kallioniemi A, Elomaa I, Kivioja AH, Nevalainen J, Böhling T, Karaharju E, Hyytinen E, Knuutila S, Kallioniemi OP. 1995. Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization. Cancer Res 55:1334-1338.
46. van Dartel M, Cornelissen PW, Redeker S, Tarkkanen M, Knuutila S, Hogendoorn PC, Westerveld A, Gomes I, Bras J, Hulse-bos TJ. 2002. Amplification of 17p11.2 approximately p12, including PMP22, TOP3A, and MAPK7, in high-grade osteosarcoma. Cancer Genet Cytogenet 139:91-96.
47. Wang X, Tournier C. 2006. Regulation of cellular functions by the ERK5 signalling pathway. Cell Signal 18:753-760.
48. Weldon CB, Scandurro AB, Rolfe KW, Clayton JL, Elliott S, Butler NN, Melnik LI, Alam J, McLachlan JA, Jaffe BM, Beckman BS, Burow ME. 2002. Identification of mitogen-activated protein kinase kinase as a chemoresistant pathway in MCF-7 cells by using gene expression microarray. Surgery 132:293-301.
49. Wong KK, Tsang YT, Shen J, Cheng RS, Chang YM, Man TK, Lau CC. 2004. Allelic imbalance analysis by high-density single-nucleotide polymorphic allele (SNP) array with whole genome amplified DNA. Nucleic Acids Res 32:e69.
50. Yasui K, Arii S, Zhao C, Imoto I, Ueda M, Nagai H, Emi M, Inazawa J. 2002. TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas. Hepatology 35:1476-1484.
51. Yasui K, Imoto I, Fukuda Y, Pimkhaokham A, Yang ZQ, Naruto T, Shimada Y, Nakamura Y, Inazawa J. 2001. Identification of target genes within an amplicon at 14q12-q13 in esophageal squamous cell carcinoma. Genes Chromosomes Cancer 32:112-118.
52. Yokoi S, Yasui K, Iizasa T, Imoto I, Fujisawa T, Inazawa J. 2003. TERC identified as a probable target within the 3q26 amplicon that is detected frequently in non-small cell lung cancers. Clin Cancer Res 9:4705-4713.
53. Yokoi S, Yasui K, Saito-Ohara F, Koshikawa K, Iizasa T, Fujisawa T, Terasaki T, Horii A, Takahashi T, Hirohashi S, Inazawa J. 2002. A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers. Am J Pathol 161:207-216.
54. Yuste L, Montero JC, Esparis-Ogando A, Pandiella A. 2005. Activation of ErbB2 by overexpression or by transmembrane neuregulin results in differential signaling and sensitivity to herceptin. Cancer Res 65:6801-6810.
55. Zhao X, Li C, Paez JG, Chin K, Jänne PA, Chen TH, Girard L, Minna J, Christiani D, Leo C, Gray JW, Sellers WR, Meyerson M. 2004. An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res 64:3060-3071.
56. Zhao X, Weir BA, LaFramboise T, Lin M, Beroukhim R, Garraway L, Beheshti J, Lee JC, Naoki K, Richards WG, Sugar-baker D, Chen F, Rubin MA, Jänne PA, Girard L, Minna J, Christiani D, Li C, Sellers WR, Meyerson M. 2005. Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis. Cancer Res 65:5561-5570.